Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
415 hedge funds and large institutions have $6.64B invested in Shockwave Medical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 159 increasing their positions, 149 reducing their positions, and 56 closing their positions.
89% more call options, than puts
Call options by funds: $58M | Put options by funds: $30.7M
16% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 56
7% more repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 149
1% more funds holding
Funds holding: 412 → 415 (+3)
28% less capital invested
Capital invested by funds: $9.21B → $6.64B (-$2.57B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$109M |
| 2 |
Millennium Management
New York
|
+$75.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$50.5M |
| 4 |
BlackRock
New York
|
+$43.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$198M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$86.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$52.8M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$49.6M |
| 5 |
FAM
Fred Alger Management
New York
|
-$41.7M |
SWAV Hedge Fund Activity: Q4 2022 in Review
415 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q4 2022, worth a combined $6.64B — down 28% from $9.21B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new SWAV positions and 56 closed out — a net gain of 9 holders — while 159 added to existing stakes and 149 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $109M. The largest seller was T. Rowe Price Associates, cutting an estimated $198M.
- 415 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q4 2022, up from 412 in Q3 2022.
- Funds reported $6.64B of Shockwave Medical, Inc. Common Stock stock for Q4 2022, down 28% quarter-over-quarter.
- 65 funds opened new Shockwave Medical, Inc. Common Stock positions in Q4 2022 and 56 closed out, a net change of +9 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q4 2022 was Wellington Management Group, an estimated $109M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q4 2022 was T. Rowe Price Associates, an estimated $198M sold.
Based on aggregated 13F filings for Q4 2022.